+ Watch AFAM
on My Watchlist
The Company and its subsidiaries is a regional provider of home health nursing services.
I think that at least in the near term, the White House's involvement in personal healthcare, being as sloppy as it is, will cause this stock and stocks like it to drop. I could end up being wrong but that is my speculation.
Almost Family announced today that customers can request their nurses be outfitted with clown costumes, ninja attire or dressed as evil robots.
Long. Visiting Nurse and Personal Care Services. Long term play on aging U.S. population.
I don't see this one going anywhere in the near term. Yes, revenue is slowly creeping up (3% or so since 2010), but EPS is going down fast (down 45% or more since 2010).
largest provider in Florida where market entry is heavily regulated by the state. More demand as baby boomers get older
Magic formula pick
A detailed article argues the upside for afam:http://seekingalpha.com/article/1112021-almost-family-micro-and-macro-strengths-at-a-disproportionate-discount?source=email_investing_ideas&ifp=0
under pressure due to gov regulations but stock price will recover as the long-term fundamentals of the health care industry emerge - lower costs, better care in terms of home health care, palliative care, and hospice services.
increased revenue by 6% compaired to last yr.same Q expected boost in in rev. 3rd Q. adoption of accountable care organization include multiptiple healthcare providers focused on on improving patient outcomes & reducing costs
Home nursing market is going to explode as the Boomers get infirm but want the comfort of their own (or their family's) home. My nurse practitioner daughter has been involved in this field for several years and is being hounded by headhunters.
Baby Boomers getting older
PSR and price to book both below 1, very nice. Also boasts outstanding ROA, about 50% better than industry average with ROI about 38% above industry average.
Aging baby boomer generation=increased demand
Small cap with good EPS growth rate. Quick Ratio of 2.9.
Double down. Regulatory concerns, yes... but demographic is aging and there is a gap to be filled between home and hospital.
$34.76 start price. down -55%.
Like what I see and seems to have been pushed too low without legit cause.
Shares down significantly in past 12 months, yet P/E at 6 and cash per share at more than 1/3 the share value today.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions